In the yeast Saccharomyces cerevisiae, complex sphingolipids have three types of polar head group, and breakdown of their normal composition causes several cellular dysfunctions. Previously we found that loss of biosynthesis of mannosylinositol phosphorylceramide (MIPC) causes a defect in cell wall integrity (CWI). In this study, we screened for multicopy suppressor genes that rescue the defect in CWI in cells lacking MIPC synthases (Sur1 and Csh1), and found that the defect is partly suppressed by upregulation of ergosterol biosynthesis. In addition, repression of expression of ERG9, which encodes squalene synthase in the ergosterol biosynthesis pathway, in sur1Δ csh1Δ cells caused a strong growth defect and enhancement of the defect in CWI. The repression of ERG9 and/or the dele
Introduction
Complex sphingolipids are some of the components of the biomembranes of eukaryotic organisms, and are required for maintenance of signal transduction systems, organelle homeostasis, and vesicular trafficking systems [1, 2] . They cluster with sterol molecules to form lipid microdomains (also called lipid rafts), which regulate the localization, activity, and interaction of various membrane-bound proteins [3] . The structure of complex sphingolipids basically consists of a polar head group and a ceramide (Cer), which contains a long-chain base and a fatty acid. In mammals, the number of polar head group structures is over 100, and the structural variation of the long-chain base and fatty acid further complicate the structural diversity of complex sphingolipids. It is widely believed that the multiple functions of complex sphingolipids are largely due to their structural diversity and complexity [4] . In the yeast Saccharomyces cerevisiae, the structural variation of complex sphingolipids is relatively simple as compared with that in mammalian cells; that is, Cer can be classified into five types according to the hydroxylation state (A, B, B 0 , C and D). According to differences in the polar head group structure, yeast complex sphingolipids can be divided into inositol phosphorylceramide (IPC), mannosylinositol phosphorylceramide (MIPC) and mannosyldiinositol phosphorylceramide (M(IP) 2 C) (Fig. 1A ) [1, 5] . Thus, S. cerevisiae is recognized as a good model for elucidation of the physiological significance of the structural diversity and complexity of complex sphingolipids.
Aur1 is an IPC synthase that catalyzes the transfer of the head group of phosphatidylinositol to Cers [6] . Deletion of AUR1 results in a lethal phenotype due to depletion of all complex sphingolipids and accumulation of Cers [6, 7] ; however, AUR1-deleted cells exhibit very slow growth when cells generate Cers having C18 fatty acids but not ones having C26 fatty acids, a primary structure of Cers in S. cerevisiae, probably because the chain length of fatty acids in Cers is a critical factor for its toxicity [8] . This also implies that IPC biosynthesis is important but not absolutely essential for yeast cell survival. Very recently, it was found that, when the total level of complex sphingolipids is decreased, the high-osmolarity glycerol pathway is activated and rescues cells from the cellular dysfunctions caused by decreases in complex sphingolipid levels, implying that yeast cells have a protection system against defects of complex sphingolipids [9] [10] [11] .
Mannosylinositol phosphorylceramides are formed through mannosylation of IPCs, which is catalyzed by two MIPC synthases, Sur1 and Csh1 [12, 13] . Ipt1, an inositolphosphotransferase, converts MIPCs to M (IP) 2 Cs [14] . Although deletion of the two MIPC synthase genes causes loss of MIPCs and M(IP) 2 Cs, sur1Δ csh1Δ cells do not exhibit a cell growth defect under normal culture conditions [15] . However, several lines of evidence have demonstrated the physiological importance of MIPC biosynthesis. For example, loss of MIPC biosynthesis causes Ca 2+ hypersensitivity and rapid death on nitrogen starvation [16] [17] [18] . These phenotypes are not due to loss of MIPC itself but to the accumulation of IPC-C [17, 19] . MIPC biosynthesis-deficient cells also exhibit a severe cell growth defect when the biosynthesis of phosphatidylserine is repressed [20] . Furthermore, the combination of repression of the phosphatidylserine synthase gene and deletion of MIPC synthase genes causes a defect in vesicular trafficking from post-Golgi endosomes to the late Golgi [21] . In addition, MIPC, but not M(IP) 2 C, activates Fpk1 kinase, which induces activation of glycerophospholipid flippases, and maintains the asymmetry of glycerophospholipids at plasma membranes [22] . These results indicate the functional relationship between MIPCs and glycerophospholipids. On the other hand, loss of MIPC and/or M(IP) 2 C affects the sensitivity to antifungal toxins syringomycin E and Dahlia merckii antimicrobial peptide 1 [23, 24] , suggesting that these specific subtypes of complex sphingolipid can be targets for some extracellular toxins. The fission yeast Schizosaccharomyces pombe has IPCs and MIPCs, but does not have M(IP) 2 Cs due to a lack of M(IP) 2 C synthase Ipt1 [25, 26] . Sc. pombe, lacking MIPC synthases, exhibits an abnormal morphology of cells and vacuoles, and a defect in internalization of plasma membrane proteins [25] .
In the previous study, to investigate the physiological significance of MIPC biosynthesis, we screened for yeast mutant strains exhibiting a synthetic lethal phenotype with loss of MIPC synthases, and found that a specific group of glycosyltransferases for the synthesis of mannan-type N-glycans, which are frequently found in cell wall and periplasm proteins, is essential for cell growth when the biosynthesis of MIPC, but not that of M(IP) 2 C, is defective [27] . Further analyses revealed that the biosynthesis of MIPC is required for the maintenance of normal cell wall function(s) [27] . In this study, we found that upregulation of ergosterol biosynthesis partially suppresses the impairment of cell wall integrity (CWI) in cells lacking MIPC synthases. Furthermore, repression of ergosterol biosynthesis markedly enhanced the impairment of CWI in cells lacking MIPC synthases. These results indicated that MIPC and ergosterol are coordinately involved in the maintenance of CWI.
Results
Screening of multicopy suppressors that suppress the SDS and caffeine hypersensitivity of MIPC biosynthesis-deficient cells
We previously reported that cells lacking MIPC synthases (Sur1 and Csh1) exhibit hypersensitivity to SDS, caffeine and zymolyase, which are hallmark features of a defect in CWI [27] [28] [29] . In the present study, to identify genes related to the defect in CWI in MIPC biosynthesis-deficient cells, we screened for multicopy suppressors that suppress the SDS hypersensitivity of sur1Δ csh1Δ cells. A pool of cells was transformed with a yeast genomic library in a high-copy number vector, YEp13, followed by screening for cells exhibiting growth in the presence of 0.01% SDS. In this screening, 186 colonies were isolated from among 70 000 transformants. Then, the isolated clones were [30] , and KES1 encodes an oxysterol-binding protein, which is involved in the transport of ergosterol from the endoplasmic reticulum to plasma membranes [31] . CCW12 encodes a cell wall protein that plays important roles in the maintenance of cell wall stability [32, 33] . In addition, a plasmid containing CCW12 or SUR1 was found when the first screening was conducted in the presence of 5 mM caffeine (data not shown). As shown in Fig. 2A , the SDS and caffeine hypersensitivities of sur1Δ csh1Δ cells were suppressed when a multicopy vector (pRS426) containing CCW12 or KES1 was introduced into the cells; however, the suppressive effect of ERG13 was weaker than that of CCW12 and KES1. Conversely, this overexpression did not confer the SDS and caffeine resistance to wild-type cells (Fig. 2B ).
Synthetic growth defect caused by deletion of a specific cell wall protein and MIPC synthesis
In addition to the fact that CCW12 functions as a multicopy suppressor conferring resistance to SDS and caffeine in sur1Δ csh1Δ cells ( Fig. 2A) , we previously observed that deletion of TOS1, encoding a cell wall protein of unknown functions, exhibits a synthetic lethal interaction with deletion of SUR1 and CSH1 [27] . To gain more insight into the relationship between cell wall proteins and MIPC, we examined the genetic interaction between MIPC synthase genes and 19 cell wall protein genes, which were found on proteome analysis of yeast cell wall [34] . In addition, Cwp2, one of the major cell wall proteins [35] , and Ccw12 were also analyzed. Among the 21 genes, ccw12Δ or tos1Δ was synthetic lethal with sur1Δ csh1Δ (Fig. 3) . The deletion of CCW12 also caused synthetic lethality with deletion of ELO2, a gene involved in sphingolipid biosynthesis, also suggesting a functional connection between Ccw12 and sphingolipids [33] . Triple deletion of SUR1, CSH1, and GAS1 caused a strong growth defect, but did not give a lethal phenotype (Fig. 3) . It has been reported that double deletion of GAS1 and CSG2, encoding a regulatory subunit of Sur1 and Csh1, causes a synthetic growth defect only when cells are exposed to hyperosmotic stress [36] . Although the deletion of SUR1 and CSH1 causes a complete loss of MIPCs and M(IP) 2 Cs, csg2Δ cells do not completely lose the ability to synthesize MIPCs from IPCs [13] ; thus, it is likely that a trace amount of MIPCs and M(IP) 2 Cs enables the growth of GAS1-deleted cells. Overall, these results indicated that MIPC synthases are required in the absence of specific cell wall proteins, which may imply some specific role(s) of MIPC in the maintenance of cell wall function.
Upregulation of ergosterol biosynthesis partly improves the impaired integrity of cell walls in MIPC biosynthesis-deficient cells
The observation that KES1 and ERG13 function as multicopy suppressors causing improvement of the SDS hypersensitivity of sur1Δ csh1Δ cells prompted us to investigate the functional relationship between the biosynthesis of MIPC and ergosterol in the maintenance of CWI. Although ERG13 is involved in an early step of ergosterol biosynthesis, farnesyl diphosphate, an intermediate of the ergosterol biosynthesis pathway, is converted to ergosterol, but also geranylgeranyl diphosphate, dolichol and ubiquinone (Fig. 1B) . Thus, to observe a specific effect of upregulation of ergosterol biosynthesis, ERG9 encoding squarene synthase (Fig. 1B ) [30] was overexpressed in sur1Δ csh1Δ cells. As shown in Fig. 4A , 10-20% increase in the ergosterol level was observed when a multicopy vector (pRS426) containing ERG9 was introduced into wild-type and sur1Δ csh1Δ cells. The increase in ergosterol level in sur1Δ csh1Δ cells harboring pRS426-ERG9 was also confirmed when cells were stained with filipin, a fluorescent probe that stains sterols (Fig. 4B) . Although sur1Δ csh1Δ cells harboring the empty vector hardly grew in the presence of 0.01% SDS, sur1Δ csh1Δ cells harboring pRS426-ERG9 exhibited weak cell growth under these conditions; however, the suppressive effect on the caffeine hypersensitivity was minor (Fig. 4C ). The growth rates of wild-type cells and sur1Δ csh1Δ cells did not greatly differ [15] (also described later); however, when a multicopy vector, such as pRS426 (also pRS425, data not shown), was transformed into sur1Δ csh1Δ cells, the growth rate was significantly retarded for an unknown reason (Fig. 4C) . Thus, the effect of overexpression of ERG9 on the SDS and caffeine sensitivities was also confirmed by replacement of the promoter region of chromosomal ERG9 with a strong constitutive TEF promoter (TEFp-ERG9) [37] . As shown in Fig. 4D , sur1Δ csh1Δ TEFp-ERG9 cells exhibited higher resistance to SDS and caffeine as compared with sur1Δ csh1Δ cells. As reported previously [27] , sur1Δ csh1Δ cells exhibited hypersensitivity to zymolyase, which is a cell wall digesting enzyme used for evaluation of CWI (Fig. 4E ) [28, 29] . The hypersensitivity to zymolyase of sur1Δ csh1Δ cells was partly relieved by the overexpression of ERG9 (Fig. 4E ). The cell density (A 600 ) of sur1Δ csh1Δ cells did not change under the experimental conditions without the addition of zymolyase (data not shown). Thus, the results indicated that ERG9 overexpression suppressed the cell lysis of sur1Δ csh1Δ cells on zymolyase treatment. In contrast, a significant difference in zymolyase sensitivity was not observed between wild-type cells harboring pRS426-ERG9 and the empty vector (Fig. 4E) . Collectively, these results indicated that an increase in the ergosterol level partly improves the impaired integrity of cell walls in sur1Δ csh1Δ cells.
Synthetic growth defect caused by repression of ERG9 and deletion of MIPC synthases
To investigate the functional relationship between MIPC and ergosterol biosynthesis, we used a mutant strain that carries the ERG9 gene under the control of a tetracycline-regulatable promoter (tet-ERG9) [9] . The mutant strain exhibited reduction in the ergosterol level in the presence of doxycycline (Dox), which is used for repression of the tetracycline-regulatable promoter [9, 38] . Figure 5A ,B shows the growth of tet-ERG9 and tet-ERG9 sur1Δ csh1Δ cells in the presence or absence of Dox. Repression of ERG9 expression reduced the cell growth rate, and the deletion of SUR1 and CSH1 significantly enhanced the reduction (Fig. 5A,B) . Significant differences in the growth rate were not observed between wild-type and sur1Δ csh1Δ cells (Fig. 5A,B) ; thus, it was suggested that MIPC biosynthesis is required for the maintenance of cell growth when ergosterol biosynthesis is impaired. To explore the possibility that the deletion of SUR1 and CSH1 has a profound effect on the ergosterol level, the effect of the deletion of SUR1 and CSH1 on the ergosterol level under both ERG9-repressive and -non-repressive . (B) Wild-type cells harboring pRS426-CCW12, pRS426-ERG13, pRS426-KES1 or the empty plasmid were cultured overnight in SC medium lacking uracil (SC-Ura), and then spotted onto SC-Ura plates with or without the indicated concentrations of SDS or caffeine in 10-fold serial dilutions starting with a density of 0.7 A 600 UÁmL À1 . All plates were incubated at 30°C and photographed after 3 days. Fig. 3 . Genetic interaction of MIPC synthase genes and cell wall protein genes. MATa Y7092 sur1Δ::LEU2 csh1Δ::URA3 cells were mated with BY4741 cells lacking a cell wall protein gene, and the resulting diploids were allowed to sporulate and then subjected to random spore analysis. Cells were selected in MATa haploid selection medium, or MATa haploid selection medium lacking uracil and leucine (sur1Δ csh1Δ selection), and/or containing G418 (selection of deletion of one of the cell wall protein genes; xxxΔ selection). The plates were incubated at 30°C for 3 days. The details are given in 'Materials and methods'.
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The FEBS Journal 285 (2018) 2405-2427 ª 2018 Federation of European Biochemical Societies conditions was examined (Fig. 5C ). As reported previously [9] , the ergosterol level in Dox-treated tet-ERG9 cells was reduced by approximately 50% as compared with those in wild-type and Dox-untreated tet-ERG9 cells, and the reduction rate was not changed by the deletion of SUR1 and CSH1 (Dox-treated tet-ERG9 cells versus Dox-treated tet-ERG9 sur1Δ csh1Δ cells) (Fig. 5C ). Thus, the results indicated that the loss of MIPC synthases does not affect the decrease in the ergosterol level caused by Dox treatment. Figure 5D shows the complex sphingolipid levels under the ERG9-repressive and -non-repressive conditions. Although a slight decrease in the MIPC level and an increase in the M(IP) 2 C level were observed due to ERG9 repression (Fig. 5D , lanes 3 and 4), a significant difference in the IPC level was not observed between sur1Δ csh1Δ and Dox-treated tet-ERG9 sur1Δ csh1Δ cells (Fig. 5D , lanes 2 and 6). Thus, the results indicated that ERG9 repression does not have profound effects on the alteration of the complex sphingolipid levels. Overall, the results indicated that the synthetic growth defect caused by ERG9 repression and the loss of MIPC synthases is not due to enhancement of the reduction in the ergosterol level due to the loss of MIPC biosynthesis or disturbance of complex sphingolipid metabolism due to the change in the ergosterol level.
Loss of MIPC biosynthesis specifically enhanced the growth defect caused by ERG9 repression
The complex sphingolipid subtypes found in S. cerevisiae are classified by three types of polar head group and five types of Cer (Fig. 1A) . The structural diversity of complex sphingolipids is created by sphingolipid-metabolizing enzymes, SUR2, SCS7, IPT1, SUR1 and CSH1 [1, 5] . The deletion of SUR2 or SCS7 causes loss of Cer-B, -C and -D, and Cer-B 0 , -C and -D, respectively [39] . In IPT1-deleted cells, M(IP) 2 Cs is not synthesized, but IPC and MIPC are synthesized [14] . To gain more insight into the structural requirement of complex sphingolipids under conditions under which ergosterol biosynthesis is decreased, SUR2, SCS7 or IPT1 was deleted in tet-ERG9 cells. As shown in Fig. 6A , no difference was observed between Dox-treated tet-ERG9 cells and Dox-treated tet-ERG9 ipt1Δ, sur2Δ or scs7Δ cells. Furthermore, sur1Δ csh1Δ cells, but not ipt1Δ, sur2Δ and scs7Δ cells, were more sensitive to miconazole, an inhibitor of Erg11 [40] , compared with wild-type cells (Fig. 6B ). As reported previously [41] , ipt1Δ cells appeared to be slightly resistant to miconazole because of impairment of uptake of the drug (Fig. 6B) . Thus, it was indicated that the loss of MIPC biosynthesis caused by the deletion of SUR1 and CSH1 specifically enhances the growth defect caused by a decrease in the ergosterol level.
Defect of the ergosterol biosynthesis pathway affects the defect in CWI of MIPC biosynthesisdeficient cells
We next examined the effects of ERG9 repression on the defect in CWI in sur1Δ csh1Δ cells. The SDS and caffeine hypersensitivities in SUR1-and CSH1-deleted cells were greatly enhanced when the expression of ERG9 was repressed (Fig. 7A) . In contrast, ERG9 repression did not affect the SDS sensitivity of SUR2-, SCS7-or IPT1-deleted cells (data not shown). Calcofluor white (CFW) binds with cell wall chitin and interferes with its polymerization, and thus is used for evaluation of CWI in yeast [42] . As reported previously [27] , sur1Δ csh1Δ cells exhibited resistance to CFW (Fig. 7B) . In contrast, the CFW sensitivity of Dox-treated ERG9 cells was much higher than those of wild-type cells and Dox-untreated tet-ERG9 cells, suggesting that a decrease in the ergosterol level causes hypersensitivity to CFW (Fig. 7B ). It has also been reported that deletion of ERG4, CBR1 or NCP1, which is involved in ergosterol biosynthesis, causes an increase in sensitivity to CFW, supporting the notion that aberrant metabolism of ergosterol affects CWI [43] . Notably, the CFW resistance of MIPC biosynthesis-deficient cells was nearly overridden by ERG9 repression (sur1Δ csh1Δ cells versus Dox-treated tet-ERG9 sur1Δ csh1Δ cells) (this will be discussed later). The ERG9 repression did not cause hypersensitivity to zymolyase even in the presence of Dox (wild-type cells versus Dox-untreated and Dox-treated tet-ERG9 cells); however, the repression significantly exacerbated the zymolyase hypersensitivity of sur1Δ csh1Δ cells (sur1Δ csh1Δ cells versus Dox-treated tet-ERG9 sur1Δ csh1Δ cells) (Fig. 7B) , indicating that ERG9 repression enhanced the cell lysis of the SUR1-and CSH1-deleted cells on zymolyase treatment. The cell lysis of sur1Δ csh1Δ and Dox-treated tet-ERG9 sur1Δ csh1Δ cells was not observed in the absence of zymolyase (data not shown). Thus, overall, the results suggested that ERG9 repression enhances the defect in CWI of sur1Δ csh1Δ cells.
Effects of simultaneous deletion of MIPC synthase genes and enzyme genes involved in the final stages of the ergosterol biosynthesis pathway A large number of ergosterol biosynthesis enzyme genes including ERG9 are essential for cell growth; however, ERG6, ERG2, ERG3, ERG5 and ERG4, which are involved in the final stages of the ergosterol biosynthesis pathway, are not essential [30] (Fig. 1B) . On the deletion of any one of these genes, sterol intermediates are accumulated instead of ergosterol, and it is believed that these compounds can partly but not completely substitute for the biological roles of ergosterol [44] . Thus, we examined the effects of deletion of ERG6, ERG2, ERG3, ERG5 or ERG4 on the SDS, caffeine and CFW sensitivities of sur1Δ csh1Δ cells (Fig. 8A,B) . The SDS hypersensitivity of sur1Δ csh1Δ cells was partly suppressed by the deletion of ERG3 or ERG5 (Fig. 8A) . In contrast, erg3Δ cells were more sensitive to SDS than wild-type cells (Fig. 8A) , and the SDS sensitivity of erg5Δ cells was also more severe than that of wild-type cells when cultured in the presence of 0.015% SDS (data not shown), indicating that the suppressive effect of the deletion of ERG3 or ERG5 on the SDS hypersensitivity of sur1Δ csh1Δ cells does not reflect the effect of a single deletion of these ergosterol biosynthesis enzyme genes. In contrast, the deletion of ERG4 or ERG6 greatly enhanced the SDS hypersensitivity of sur1Δ csh1Δ cells (Fig. 8A) . Similarly, the caffeine sensitivity of erg4Δ sur1Δ csh1Δ and erg6Δ sur1Δ csh1Δ cells was severer than that of sur1Δ csh1Δ cells (Fig. 8A) . The deletion of ERG2, ERG4 or ERG6 caused hypersensitivity to CFW, and these deletions overrode the CFW resistance of the SUR1-and CSH1-deleted cells; that is, the CFW sensitivity of these triple mutants was much higher than that of wild-type cells (Fig. 8B) . The effects of the deletion of ERG3 or ERG5 on the CFW sensitivity of the SUR1-and CSH1-deleted cells were relatively weak, as compared with that of ERG2, ERG4 or ERG6 (Fig. 8B) . Collectively, these results indicated that the defect in CWI of sur1Δ csh1Δ cells is affected by changes in the detailed structure of ergosterol. They also suggested that a simultaneous defect of a detailed structure of complex sphingolipid and ergosterol has synergistic effects on CWI, implying that cells are able to adapt and compensate for a structural defect in one lipid class, complex sphingolipid or ergosterol, but a defect in both classes cannot be compensated.
Activation of the CWI pathway on deletion of MIPC synthase genes and/or repression of ERG9 When cell wall functions are impaired, a mitogen-activated protein kinase (MAPK) cascade, termed the CWI pathway, is activated, and the transcription of genes involved in construction of the cell wall is upregulated [28, 29] (Fig. 9A) . Previously, we found that level of phosphorylated Slt2, a MAPK in the CWI pathway, is increased in sur1Δ csh1Δ cells [27] . Thus, we next examined the effect of ERG9 repression on the phosphorylation of Slt2 (Fig. 9B) . The chromosomal SLT2 was tagged with 6xHA at the C terminus, and the protein was detected with an anti-HA antibody and the phosphorylated Slt2-6xHA was detected with an anti-phospho-p44/22 MAPK antibody [27] . As reported previously [27] , an increase in the phosphorylated Slt2-6xHA level was observed in sur1Δ csh1Δ cells as compared with wild-type cells (Fig. 9B) . Doxuntreated and Dox-treated tet-ERG9 cells also exhibited an increased level of phosphorylated Slt2-6xHA; however, the level of the phophorylated form in Doxtreated cells was higher than that in Dox-untreated ones. Although the ergosterol level in Dox-untreated tet-ERG9 cells was comparable to that in wild-type cells (Fig. 5C) , it is possible that, even in the absence Fig. 4 . Overexpression of ERG9 improves CWI in sur1Δ csh1Δ cells. Wild-type and sur1Δ csh1Δ (STY39) cells harboring pRS426-ERG9 or the empty plasmid were cultured overnight in SC-Ura. Lipids were extracted and then separated by TLC. Ergosterol was visualized with a copper and orthophosphoric acid reagent, and quantified with IMAGEJ software (NIH). Data represent means AE SD for one experiment (triplicate) representative of three independent experiments. Statistical analysis was performed using Student's t test, and the P values obtained are indicated. The asterisk indicates an unidentified band. (B) sur1Δ csh1Δ cells harboring pRS426-ERG9 or the empty plasmid were cultured overnight in SC-Ura, stained with filipin and then observed by fluorescence microscopy. The graphs indicate the frequency distribution of filipin fluorescence intensity in individual cells. The fluorescence intensity was quantified with IMAGEJ software. Data represent the value for 100 cells for each strain. The details are given under 'Materials and methods'. (C) Wild-type and sur1Δ csh1Δ (STY39) cells harboring pRS426-ERG9 or the empty plasmid were cultured overnight in SC-Ura, and then spotted onto SC-Ura plates with or without the indicated concentrations of SDS or caffeine in 10-fold serial dilutions starting with a density of 7 A 600 UÁmL
À1
. Plates were incubated at 30°C and photographed after 3 days. (D) Wild-type, sur1Δ csh1Δ (STY39), TEFp-ERG9 and sur1Δ csh1Δ TEFp-ERG9 cells were cultured overnight in SC medium, and then spotted onto SC plates with or without the indicated concentrations of SDS or caffeine in 10-fold serial dilutions starting with a density of 0.7 A 600 UÁmL À1 . All plates were incubated at 30°C and photographed after 3 days. (E) Zymolyase sensitivity. Cells were cultured overnight in SC-Ura. They were washed with H 2 O, resuspended (1.5 A 600 unitsÁmL
) in 20 mM HEPES buffer (pH 7.5) containing 15 lgÁmL À1 zymolyase-20T (Nacalai Tesque, Kyoto, Japan), and incubated at 30°C. Aliquots of cell suspensions were subjected to cell density measurements (A 600 ) at the indicated times. Data represent means AE SD for one experiment (triplicate) representative of three independent experiments. Statistical analysis was performed using Student's t test, and the P values obtained are indicated.
of Dox, substitution of the promoter region of ERG9 results in aberrant metabolism of ergosterol that is undetectable on TLC analysis, and thus causes the increased level of phosphorylated Slt2-6xHA. Notably, the phosphorylated Slt2-6xHA was dramatically increased in Dox-treated tet-ERG9 sur1Δ csh1Δ cells (Fig. 9B ), indicating that a simultaneous metabolic defect of ergosterol and MIPC enhances the activation of the CWI pathway. Similar results were obtained when Slt2 was not tagged with 6xHA (data not shown). Also, it should be noted that the total expression level of Slt2-6xHA in sur1Δ csh1Δ, tet-ERG9 and tet-ERG9 sur1Δ csh1Δ cells was higher than in wildtype cells (Fig. 9B ). The increase in expression level of Slt2-6xHA was also observed when MNN2, encoding a glycosyltransferase gene involved in the synthesis of mannan-type N-glycans, was repressed and SUR1 and CSH1 were deleted [27] . Deletion of SLT2 caused enhancement of the growth defect of the ERG9-repressed and the ERG9-repressed sur1Δ csh1Δ cells (Fig. 9C) , indicating that the CWI pathway is required for the maintenance of the growth of these cells. Notably, addition of 1 M soribitol, an osmostabilizer preventing the growth defects caused by defects in CWI ) in fresh YPD medium with or without 10 lgÁmL À1 Dox, and then incubated for 8 h at 30°C. Lipids were extracted and then separated by TLC.
In the complex sphingolipid analysis, the samples were subjected to mild alkaline treatment using monomethylamine before application to a TLC plate. The lipids were visualized with a copper and orthophosphoric acid reagent, and quantified with IMAGEJ software. Data represent means AE SD from three independent experiments. Statistical analysis was performed using Student's t test, and the P values obtained are indicated. The asterisk indicates an unidentified band. The details are given in 'Materials and methods'. Fig. 6 . Effect of deletion of sphingolipid-metabolizing enzyme genes under ergosterol biosynthesis-repressive conditions. tet-ERG9, tet-ERG9 sur1Δ csh1Δ, tet-ERG9 ipt1Δ, tet-ERG9 sur2Δ and tet-ERG9 scs7Δ cells were cultured overnight in YPD medium, and then spotted onto YPD plates with or without 10 lgÁmL À1 Dox in 10-fold serial dilutions starting with a density of 0.7 A 600 UÁmL
. (B) Wild-type, sur1Δ csh1Δ (STY39), ipt1Δ, sur2Δ and scs7Δ cells were cultured overnight in YPD medium, and then spotted onto YPD plates with or without the indicated concentrations of miconazole in 10-fold serial dilutions starting with a density of 0.7 A 600 UÁmL
. All plates were incubated at 30°C and photographed after 2 days (A) or 1 day (B). [28, 29] , suppressed the growth defect of tet-ERG9 slt2Δ and tet-ERG9 sur1Δ csh1Δ slt2Δ cells in the presence of 0.1 lgÁmL À1 Dox (Fig. 9C) , suggesting that the growth defect of these mutant cells is caused by increased sensitivity to hypo-osmotic stress due to the defect in CWI. However, in the presence of a high concentration (10 lgÁmL À1 ) of Dox, sorbitol did not suppress these growth defects (Fig. 9C ). The addition of 1 M sorbitol also induces hyper-osmotic stress [45] , and we previously found that repression of MNN2 causes hypersensitivity to hyper-osmotic stress in sur1Δ csh1Δ [27] ; thus, it is possible that ERG9 repression and the deletion of SUR1 and CSH1 also cause an increase in sensitivity to hyper-osmotic stress. The activation of the CWI pathway due to impaired integrity of the cell wall is mediated by CWI sensor proteins, which are plasma membrane-localized proteins that recognize aberration of cell walls [28, 29] (Fig. 9A ). To investigate whether or not deletion of CWI sensors also affects the growth defect of Dox- treated tet-ERG9 sur1Δ csh1Δ cells, genes encoding the main CWI sensors (WSC1 and MID2) were deleted. As shown in Fig. 9D , the single deletion of WSC1 or MID2 had no effect on the cell growth; however, double deletion of WSC1 and WSC2, encoding a minor CWI sensor [46] , enhanced the growth defect of Doxtreated tet-ERG9 sur1Δ csh1Δ cells (Dox-treated tet-ERG9 sur1Δ csh1Δ cells versus Dox-treated tet-ERG9 sur1Δ csh1Δ wsc1Δ wsc2Δ cells). In contrast, there was no notable difference in cell growth between wild-type and wsc1Δ wsc2Δ cells (data not shown). Deletion of WSC3, encoding another minor CWI sensor, had no effect (Fig. 9D) . We also tried to create tet-ERG9 sur1Δ csh1Δ wsc1Δ mid2Δ cells; however, the transformation of cells failed, maybe due to these multiple mutations causing synthetic lethality. Moreover, the deletion of WSC1 and WSC2 decreased the phosphorylated Slt2 level in Dox-treated tet-ERG9 sur1Δ csh1Δ cells (Fig. 9E) . Thus, the results indicated that the activation of the CWI pathway in Dox-treated tet-ERG9 sur1Δ csh1Δ cells is mediated, at least partly, by the CWI sensors.
Repression of ERG9 causes an increase in the cell wall chitin level
Upon cell wall stress, the chitin level in cell walls is dynamically regulated to reinforce the cell walls [28, 29] . To investigate whether or not ERG9 repression and/or loss of MIPC synthases affect the chitin level, cell wall chitin was stained with CFW ( Fig. 10) . As reported previously [27] , a notable difference in the fluorescence intensity of CFW on the cell surface was not observed between wild-type and sur1Δ csh1Δ cells (Fig. 10) . In contrast, the repression of ERG9 greatly increased the fluorescence intensity (wild-type cells versus Dox-treated tet-ERG9 cells), suggesting an increase in the cell wall chitin level due to the decrease in ergosterol biosynthesis (Fig. 10) . We also confirmed that Dox treatment does not cause an increase in the fluorescence intensity in wild-type cells (data not shown). An increase in the chitin level was similarly observed in Dox-treated tet-ERG9 sur1Δ csh1Δ cells (Fig. 10) . Deletion of CHS3 encoding chitin synthase required for the biosynthesis of the majority of cell wall chitin caused a dramatic decrease in the cell surface chitin level in the ERG9-repressed sur1Δ csh1Δ cells; however, the fluorescence intensity of Dox-treated tet-ERG9 sur1Δ csh1Δ chs3Δ cells was still higher than that of chs3Δ cells (Fig. 10) , suggesting that other chitin synthases, Chs1 and/or Chs2, may also be involved in the increase in the chitin level in ERG9-repressed sur1Δ csh1Δ cells. The deletion of SLT2 or WSC1/2 did not reduce the cell wall chitin level in the ERG9-repressed sur1Δ csh1Δ cells (Fig. 10) , indicating that the CWI pathway is not involved in the increase in the chitin level.
Discussion
In this study, we have shown a functional relationship between the biosynthesis of MIPC and ergosterol; that is, the repression of ergosterol biosynthesis causes a synthetic growth defect with the deletion of SUR1 and CSH1, and enhances the defect in CWI in sur1Δ csh1Δ cells ( Figs 5, 7 , and 11B). On the contrary, upregulation of ergosterol biosynthesis partly improved the defect in CWI in sur1Δ csh1Δ cells (Fig. 4) , suggesting that the loss of MIPC synthases is at least partly compensated by ergosterol (Fig. 11A) . In sur1Δ csh1Δ cells, MIPCs and M(IP) 2 Cs are not produced; however, the combination of ERG9 repression and deletion of IPT1 encoding M(IP) 2 C synthase did not cause a synthetic growth defect (Fig. 6) , implying that the loss of M(IP) 2 Cs is not critical for abnormal phenotypes in ERG9-repressed sur1Δ csh1Δ cells. A Ca 2+ -sensitive phenotype of MIPC-biosynthesis-deficient cells is caused by accumulation of IPC-C, but not by loss of MIPCs itself [19] ; however, the SDS hypersensitivity of the ERG9-repressed sur1Δ csh1Δ cells was not cancelled on deletion of the sphingolipid hydroxylase gene (SCS7 or SUR2), which causes loss of IPC-C production, suggesting that abnormal phenotypes in ERG9-repressed sur1Δ csh1Δ cells are not caused by the accumulation of IPC-C (data not shown). In addition, CWI defects caused by the repression of MNN2 and the deletion of SUR1 and CSH1 are also caused by loss of MIPC itself, but not by the accumulation of IPC-C [27] . Thus, collectively, these results suggested that MIPCs and ergosterol are coordinately involved in the maintenance of CWI.
Importantly, the activation of Slt2, which was at least partly triggered by the CWI sensor proteins Wsc1 and Wsc2, was involved in suppression of the growth defect of the ERG9-repressed sur1Δ csh1Δ cells (Fig. 9) , implying that the defect in CWI caused by the double metabolic defects of ergosterol and MIPC is kept to a minimum by the activation of the CWI pathway. On the other hand, the activation of Slt2 is also caused by the activation of target of rapamycin complex 2 (TORC2) [47] , and the deletion of SUR1 increases the phosphorylation of Ypk1 kinase via TORC2 [48] . Thus, the possibility that the activation of the CWI pathway by ERG9 repression and/or the deletion of SUR1 and CSH1 are partly mediated by TORC2 should also be considered.
sur1Δ csh1Δ cells exhibit resistance to CFW [27] (Fig. 7B) . In some cases, the acquisition of resistance to CFW is caused by impairment of the CWI pathway (for example, the deletion of RLM1 or MID2 [27, 49] ) because of the decrease in stress-induced chitin biosynthesis. However, the deletion of SUR1 and CSH1 does not affect the cell wall chitin level, and sur1Δ csh1Δ cells are hypersensitive to CFW in the absence of Slt2 [27] (Fig. 10) . Moreover, in the presence of CFW, the increase in phosphorylated Slt2 level in sur1Δ csh1Δ cells is higher than that in wild-type cells [27] . Thus, it is suggested that the resistance to CFW of sur1Δ csh1Δ cells is due to hyperactivation of the CWI pathway, and when Slt2 is absent sur1Δ csh1Δ cells exhibit CFW hypersensitivity because of an inability to maintain sufficient CWI. In this study, it was found that the resistance to CFW of the SUR1-and CSH1-deleted cells is greatly reduced by ERG9 repression (Fig. 7B) , or the deletion of ERG2, ERG4 or ERG6 (Fig. 8B) , indicating that the defects in ergosterol biosynthesis overrode the CFW resistance caused by the loss of MIPC biosynthesis. However, the level of phosphorylated Slt2 in the ERG9-repressed sur1Δ csh1Δ cells was much higher than that in the sur1Δ csh1Δ cells and ERG9-repressed cells (Fig. 9A) , implying that the cancellation of the CFW resistance due to ERG9 repression is not caused by inhibition of the CWI pathway, but is likely due to a more profound defect in CWI caused by the double metabolic defect in complex sphingolipids and ergosterol.
Complex sphingolipids together with ergosterol play important roles in the formation of lipid rafts [50] . Several lines of evidence have demonstrated the structural requirement of complex sphingolipids and ergosterol for maintenance of proper raft formation. For example, double mutation of ELO3, involved in the biosynthesis of C26 fatty acyl-CoA, and ERG6 causes destabilization of lipid rafts [51] . Although the chain length of fatty acids in Cers is primarily C26 in S. cerevisiae, Cers and complex sphingolipids containing C22/C24-fatty acids are produced in the absence of ELO3 [52] . Erg6 catalyzes the introduction of a methyl group at position 24 of the basic sterol backbone [30] .
Thus, it is assumed that impairment of the hydrophobic interaction between the Cer moiety of complex sphingolipids and sterols due to the decreases in the lengths of both carbon chains affects the stability of lipid rafts [51] . In addition, some specific double deletion combination of the Cer hydroxylase gene, SCS7 or SUR2, and ERG2, ERG3, ERG4, ERG5 or ERG6, cause a synthetic growth defect under several stress conditions including cell wall stress, such as that with SDS, caffeine and CFW treatment [53] . On the other hand, it has also been reported that complex sphingolipids and ergosterol form distinct domains at yeast plasma membranes.
Aresta-Branco et al. [54] revealed that yeast plasma membranes have a sphingolipid-enriched solid-like gel domain, which does not require ergosterol. Furthermore, complex sphingolipids are mainly localized at the outer leaflet of plasma membrane; however, the majority of ergosterol is localized at the inner leaflet [55] . Thus, the possibility should also be considered that MIPCs and ergosterol are coordinately involved in the maintenance of CWI, even if they are present in different membrane domains and do not have direct physical interaction.
Even in the absence of MIPC biosynthesis, IPCs are still synthesized, and the total level of complex 2 Cs are enriched in plasma membranes [56] . Thus, when IPCs are the sole complex sphingolipids due to loss of MIPC synthases, the functional and/or physical interaction between complex sphingolipids and ergosterol at plasma membranes may be decreased. It has been known that the proper formation of lipid rafts at the trans-Golgi network (TGN) is important for trafficking of glycosylphosphatidylinositol (GPI)-anchored proteins, essential components of the cell wall, from the TGN to plasma membranes [57] . Secretory vesicles that contain proteins localized to lipid rafts are enriched in complex sphingolipids and ergosterol as compared with the TGN/endosome compartments and plasma membranes, suggesting that GPI-anchored proteins are transported to plasma membranes together with complex sphingolipids and ergosterol [58, 59] . Thus, it is possible that the double defect of MIPC and ergosterol biosynthesis causes aberrant trafficking of GPIanchored proteins, or upregulation of ergosterol biosynthesis improves the aberrant trafficking due to loss of MIPC biosynthesis. However, green fluorescent proteintagged Cwp2, a major GPI-anchored protein in the cell wall [35] , exhibited a normal cell-surface distribution in sur1Δ csh1Δ and ERG9-repressed sur1Δ csh1Δ cells (S. Tanaka and M. Tani, unpublished results). However, the possibility should be considered that sur1Δ csh1Δ and/or ERG9-repressed sur1Δ csh1Δ cells have abnormalities in trafficking of some specific GPIanchored proteins. The fact that the deletion of SUR1 and CSH1 causes synthetic lethality with specific cell wall proteins (Fig. 3 ) may suggest the loss of function of specific cell wall protein(s) due to loss of MIPCs.
In summary, the present study suggests that MIPC and ergosterol are coordinately involved in maintenance of CWI. Further detailed investigation as to the functional interaction between the biosynthesis of MIPC and ergosterol will provide new insights into the physiological functions and physiological significance of the structural diversity of complex sphingolipids.
Materials and methods

Yeast strains and media
The S. cerevisiae strains used are listed in Table 1 . To generate a yeast in which the expression of ERG9 is regulated by doxycycline (Dox), the ERG9 upstream region was replaced with a tetracycline operator cassette containing a repressor binding site (tetO 2 ), the gene encoding the TetR-VP16 tTA transactivator and a kanMX4 marker, as described previously [38] . Disruption of genes was performed by replacing their ORFs with the kanMX4 marker from a genome from a yeast knockout library, or the pFA6a-kanMX4 vector, the hphNT1 marker from the pFA6a-hphNT1 vector, the natNT2 marker from the pFA6a-natNT2 vector [37, 60] , the natMX4 marker from the p4339 vector (pCRII-TOPO::natMX4) [61] , the URA3 marker from pRS406, or the LEU2 marker from the pRS405 vector [62] . Occasionally, kanMX4 and natMX4 were replaced with the hygromycin B-resistant gene (from the pFA6a-hphNT1 vector) to create hphMX4. For overexpression of genes due to a strong and constitutive TEF promoter, a TEF promoter cassette with the kanMX4 marker from pYM-N18 was introduced immediately upstream of the initiator ATG of the chromosomal gene, as described previously [37] . For tagging of the C terminus of SLT2 with six copies of the HA epitope (6xHA), a 6xHA fusion cassette with the hphNT1 marker from the pYM16 vector was introduced immediately upstream of the stop codon of chromosomal SLT2 as described previously [27] . The cells were cultured in YPD medium (1% yeast extract, 2% peptone, and 2% glucose), SC (synthetic complete) medium (0.67% yeast nitrogen base without amino acids (BD Difco, Heidelberg, Germany), 2% glucose and nutritional supplements), SC/MSG medium (0.17% yeast nitrogen base without amino acids and ammonium sulphate (BD Difco, Heidelberg, Germany), 0.1% L-glutamic acid sodium salt hydrate (MSG; Sigma-Aldrich, St Louis, MO, USA), 2% glucose, and nutritional supplements).
Plasmids
A multicopy plasmid (pRS426 [63] ) containing CCW12, ERG13, KES1 or ERG9, and its 5 0 -and 3 0 -untranlated regions (500 and 499 bp for CCW12, ERG13 and KES1, and 500 and 500 bp for ERG9, respectively) was constructed as described below. A DNA fragment was amplified by PCR using a 5 0 primer ( 
Multicopy suppressor screening
A S. cerevisiae genomic DNA library based on YEp13, a multicopy vector with the LEU2 marker (provided by A. Nakano, Riken, Japan), was introduced into sur1Δ csh1Δ (MTY1470) cells. After the transformation, the cells were plated on SC plates lacking leucine but containing 0.01% SDS, and then incubated at 30°C for 3 days. Colonies were re-streaked onto SC plates lacking leucine but containing 5 mM caffeine, and growth was observed. Plasmids extracted from the isolated clones were re-transformed into sur1Δ csh1Δ cells, and the SDS and caffeine sensitivities were confirmed. Plasmid DNA from positive clones was isolated and amplified in Escherichia coli, and the DNA sequences were verified with an ABI PRISM Ò 3100 genetic analyzer (Applied Biosystems, Foster, CA, USA).
Random spore analysis
To observe the synthetic genetic interaction, random spore analysis was performed according to the method of [61] , using BY4741 (MATa) strains from a yeast knockout library (OpenBiosystems, Huntsville, AL, USA) and the Y7092 (MATa) strain [61] . The selection media used for this study were as follows: SC/MSG lacking histidine, arginine and lysine, but containing 25 lgÁmL À1 canava- 
Lipid extraction and TLC analysis
Lipids were extracted from S. cerevisiae as described previously [64] with minor modifications. Briefly, cells [3 A 600 U (for detection of complex sphingolipids), and 1.5 A 600 U (for detection of ergosterol)] were suspended in 350 lL of ethanol/water/diethyl ether/pyridine/15 M ammonia (15 : 15 : 5 : 1 : 0.018, v/v), and then incubated at 65°C for 15 min. The lipid extract was centrifuged at 10 000 g for 1 min and then extracted once more in the same manner. For analysis of sphingolipids, but not ergosterol, the resulting supernatant was dried and subjected to mild alkaline treatment using monomethylamine. For this reason, the lipid extract was dissolved in 130 lL monomethylamine (40% methanol solution)/water (10 : 3, v/v), incubated for 1 h at 53°C, and then dried. The lipids were suspended in 60 lL of chloroform/methanol/water (5 : 4 : 1, v/v), and then separated on Silica Gel 60 TLC plates (Merck, Whitehouse Station, NJ, USA) with chloroform/methanol/4.2 M ammonia (9 : 7 : 2, v/v) (for detection of complex sphingolipids), or hexane/diethyl ether/acetic acid (30 : 70 : 1, v/v) (for detection of ergosterol) as the solvent system. The TLC plates were sprayed with 10% copper sulphate in 8% orthophosphoric acid and then heated at 180°C to visualize lipids. Identification of each complex sphingolipid was performed as described previously [65] .
Yeast protein extraction, SDS/PAGE and western blotting
Yeast cells grown in YPD medium were collected by centrifugation, washed with water, and then resuspended in 100 lL of 0.2 M NaOH containing 0.5% 2-mercaptoethanol. The suspension was incubated on ice for 15 min; 1 mL of ice-cold acetone was added to the suspension, followed by incubation for 30 min at À20°C, and then the proteins were precipitated by centrifugation for 5 min at 15 000 g. The pellet was resuspended in 100 lL of SDS sample buffer (156 mM Tris/HCl, pH 6.8, containing 5% SDS, 25% glycerol, 5% 2-mercaptoethanol and 0.001% bromophenol blue). The suspension was mixed well, heated for 3 min at 95°C, and then centrifuged for 3 min at 15 000 g. Then the supernatant was separated by SDS/PAGE according to the method of Laemmli [66] . For western blotting, anti-phospho-p44/42 MAPK (Cell Signaling Technology, Danvers, MA, USA), anti-HA (Sigma-Aldrich) and anti-Pgk1 (Thermo Fisher Scientific, Waltham, MA, USA) were used as primary antibodies. Horseradish peroxidase-conjugated anti-mouse or antirabbit IgG (Thermo Fisher Scientific) was used as the secondary antibody.
Filipin staining
Filipin staining of yeast cells was performed as described in Ref. [25] with minor modification. Briefly, filipin was added to the medium at a final concentration of 15 lgÁmL À1 , and cells were observed immediately using a fluorescence microscope (Leica DMRB; Leica, Solms, Germany).
Calcofluor white staining CFW staining of yeast cells was performed as described previously [67] with minor modification. Briefly, yeast cells were collected by centrifugation and fixed with 500 lL of 2% paraformaldehyde in PBS for 30 min. After washing twice with PBS, the cells were incubated with 10 lgÁmL
À1
CFW in PBS for 30 min at room temperature. Then, the cells were washed twice with PBS and viewed under a fluorescence microscope.
